The PROLONG Trial - Rituximab Maintenance Therapy in ITP

Clinical trial NCT03010202 · UNKNOWN

Trial details

NCT number: NCT03010202
Sponsor: Ostfold Hospital Trust
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Purpura, Thrombocytopenic, Idiopathic

Start date: 2016-12-01
Primary completion: 2024-12-01
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.